Ac Immune Sa (ACIU) Live Share Price, Invest From India

Ac Immune Sa Stock Performance

as on October 25, 2025 at 1:29 am IST

Day's Low
Day's High
$2.81
Day's Price Range
$3.3
$3.25
13.54%
Downside
1.54%
Upside
52 Week's Low
52 Week's High
$1.43
52-Week Price Range
$3.99
$3.25
56.00%
Downside
22.77%
Upside

Ac Immune Sa share price movements today

Previous Close: $2.81
Open: $2.81
Volume: 864.1K
Day's Low - High: $2.81 - $3.3
52 Week Low - High: $1.43 - $3.99

Ac Immune Sa Historical Returns

1 Month Return: + 11.68 %
3 Month Return: + 33.74 %
1 Year Return: + 6.56 %
3 Year Return: + 9.24 %
5 Year Return: -34.87 %

Ac Immune Sa Stock Fundamentals & Key Indicators

Check Ac Immune Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$282.7M

EPS (TTM)

-0.726

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-48.7M

Revenue (TTM)

28.9M

Profit Margin

-174.67%

Return On Equity TTM

-50.98%

Ac Immune Sa vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ac Immune Sa with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ac Immune Sa	BUY	$282.7M	-34.87%	NA	-174.67%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	251.51%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$109.3B	99.16%	30.04	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$62.0B	-0.32%	14.51	31.37%

Stock Returns calculator for Ac Immune Sa Stock including INR - Dollar returns

The Ac Immune Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Ac Immune Sa investment value today

Current value as on today

₹1,11,164

Returns

₹11,164

(+11.16%)

Returns from Ac Immune Sa Stock

₹6,557 (+6.56%)

Dollar Returns*

₹4,606 (+4.61%)

Analyst Recommendation on Ac Immune Sa Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ac Immune Sa. Average target price of $9.73

Ac Immune Sa Share Price Target

Get share price movements and forecasts by analysts on Ac Immune Sa.

What analysts predicted

66.6%UPSIDE

Target Price

$9.73

Current Price

$3.25

Analyzed by

9 Analysts

Target

$9.73

Ac Immune Sa target price $9.73, a slight upside of 66.6% compared to current price of $3.25. According to 9 analysts rating.

Ac Immune Sa Stock’s Investor Sentiment and Interest

Search interest for Ac Immune Sa Stock has increased by 219% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 26, 2025 to October 26, 2025

Change:219% versus previous 30 day period

Ac Immune Sa Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	17	0	0	30	1	1	1
Gross Profit	-14	-15	-13	0	-17	-18	30	1	1	1
Operating Income	-17	-17	-15	-3	-20	-20	7	-18	-19	-19
EBITDA	-16	-16	-14	-4	-18	-22	6	-15	-18	-20
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-17	-16	-15	-4	-17	-22	5	-15	-19	-21
Income Tax Expense	0	0	0	0	0	-	-	0	-	-
Net Income	-18	-18	-16	-5	-20	-25	6	-17	-21	-21
Net Profit Margin	0.00%	0.00%	0.00%	-32.05%	-2600.00%	-3312.95%	21.59%	-1389.36%	-1922.12%	-1622.43%

Ac Immune Sa Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	39	22	20	7	112	17	1	4	17	30
Gross Profit	22	-2	-12	-37	61	-49	-67	-60	-46	30
Operating Income	18	-10	-22	-49	44	-61	-79	-70	-53	-52
EBITDA	18	-6	-22	-49	44	-61	-77	-69	-51	-48
Interest Expense	0	0	0	0	1	0	0	0	0	0
Depreciation	-	-	0	0	1	1	2	2	2	2
Income Before Tax	20	-7	-26	-50	45	-61	-72	-70	-54	-50
Income Tax Expense	1	3	0	-1	1	0	0	0	0	0
Net Income	20	-6	-26	-51	46	-69	-79	-75	-62	-57
Net Profit Margin	51.85%	-30.57%	-130.39%	-708.24%	40.93%	-402.47%	-7732.63%	-1798.04%	-366.41%	-186.44%

Ac Immune Sa Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-16	-15	-4	-17	-22	5	-15	-19	-21
Operating Cash Flow	-14	-13	-16	1	73	-14	5	-18	-15
Investing Cash Flow	-5	4	23	-23	-75	-2	-3	3	23
Financing Cash Flow	1	0	41	0	0	0	0	0	0
Change in Cash	-17	-8	46	-21	-5	-19	3	-16	5

Ac Immune Sa Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-26	-50	45	-61	-72	-70	-54	-50
Operating Cash Flow	-5	-22	-44	55	-59	-65	-73	-60	65
Investing Cash Flow	0	-1	-32	-66	28	-53	23	65	-105
Financing Cash Flow	78	0	109	49	0	40	-1	43	-1
Change in Cash	75	-27	32	37	-32	-78	-50	46	-42

Global Institutional Holdings in Ac Immune Sa

Funds	Holdings
Bvf Inc	19.7%
Wells Fargo & Co	1.02%
Renaissance Technologies Corp	0.82%
BlackRock Inc	0.41%
Northern Trust Corp	0.38%

See all

Insights on Ac Immune Sa

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ACIU stock has moved up by 12.1%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 990.0K → 1.30M (in $), with an average increase of 24.2% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.4% return, outperforming this stock by 124.2%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 56.1%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 5.50M → -21.18M (in $), with an average decrease of 139.6% per quarter

About Ac Immune Sa

ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor

Organisation	Ac Immune Sa
Headquarters	Building B, Lausanne, Switzerland, 1015
Industry	Health Technology
CEO	Dr. Andrea Pfeifer Ph.D.
E-voting on shares	Click here to vote

Key Management of Ac Immune Sa

Name	Title
Dr. Gary Anthony Waanders Ph.D.	Senior VP of Investor Relations & Corporate Communications
Mr. Mark Danton	Executive Vice President of Information Systems & Artificial Intelligence
Dr. Günther Staffler Ph.D.	Interim Executive Vice President of Development
Mr. Howard Donovan	Chief Human Resources Officer
Mr. Christopher Roberts	CFO & VP of Finance
Mr. Piergiorgio Donati	Chief Technical Operations Officer
Dr. Matthias Maurer Ph.D.	Senior VP & General Counsel
Dr. Oliver Sol M.D.	VP & Head of Clinical Development
Dr. Julien Rongere Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance
Dr. Andrea Pfeifer Ph.D.	Co-Founder, CEO & Director

FAQs

What is Ac Immune Sa share price today?

Ac Immune Sa share price today is $3.25 as on October 25, 2025 at 1:29 am IST at the close of the market. Ac Immune Sa share today touched a day high of $3.3 and a low of $2.81.

What is the 52 week high and 52 week low for Ac Immune Sa share?

Ac Immune Sa share touched a 52 week high of $3.99 on October 3, 2025 and a 52 week low of $1.43 on April 9, 2025. Ac Immune Sa stock price today i.e. October 25, 2025 at 1:29 am IST is closed at $3.25,which is 18.55% down from its 52 week high and 127.29% up from its 52 week low.

What is Ac Immune Sa's market capitalisation today?

Ac Immune Sa market capitalisation is $0.00T as on October 25, 2025 at 1:29 am IST.

How to invest in Ac Immune Sa Stock (ACIU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ac Immune Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ac Immune Sa Shares that will get you 0.4615 shares as per Ac Immune Sa share price of $3.25 per share as on October 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ac Immune Sa Stock (ACIU) from India?

Indian investors can start investing in Ac Immune Sa (ACIU) shares with as little as ₹87.796 or $1 (as of October 26, 2025 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Ac Immune Sa stock (as per the Rupee-Dollar exchange rate as on October 26, 2025 at 2:37 am IST). Based on Ac Immune Sa share’s latest price of $3.25 as on October 25, 2025 at 1:29 am IST, you will get 3.0769 shares of Ac Immune Sa. Learn more about fractional shares .

What are the returns that Ac Immune Sa has given to Indian investors in the last 5 years?

Ac Immune Sa stock has given -34.87% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?